EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Alterations in splanchnic cyclic nucleotide levels in splanchnic artery occlusion shock and their modification by dexamethasone



Alterations in splanchnic cyclic nucleotide levels in splanchnic artery occlusion shock and their modification by dexamethasone



European Journal of Pharmacology 37(1): 63-70



The effects of dexamethasone sodium phosphate (DSP), 5 mg/kg, administration on the biochemical alterations in hepatic tissue subsequent to the production of splanchnic artery occlusion (SAO) shock was investigated. Following the induction of SAO shock, DSP-treated dogs exhibited a significantly improved cardiovascular status compared to placebo-treated shock dogs. Two hours after release of the occlusion, biopsies of liver were taken and analyzed for .beta.-glucuronidase (BG), cyclic AMP (cAMP) and cGMP content. SAO shock produced a significant increase in hepatic free BG activity which was reversed by DSP pretreatment. SAO shock decreased hepatic cAMP levels, increased cGMP levels and significantly lowered the hepatic ratio of cAMP/cGMP. These changes in cyclic nucleotide levels were reversed by DSP administration and were inversely related to changes in hepatic free BG activity. The ratio of cellular cAMP/cGMP may function as a regulatory mechanism for lysosomal enzyme release secondary to ischemia and hypoxia. DSP may act to maintain lysosomal integrity in ischemic tissues by preservation of cAMP/cGMP ratios.

(PDF emailed within 0-6 h: $19.90)

Accession: 004703928

Download citation: RISBibTeXText

PMID: 179827

DOI: 10.1016/0014-2999(76)90008-x



Related references

Splanchnic artery occlusion shock in the rats Effects of clevidipine and sodium nitroprusside on splanchnic hemodynamics. FASEB Journal 11(3): A285, 1997

Hemodynamic alterations in splanchnic arterial occlusion shock and the effects of dexamethasone sodium phosphate. Circulatory Shock 2(4): 287-299, 1975

Cardiac performance in splanchnic artery occlusion shock effect of dexamethasone. Federation Proceedings 33(3 PART 1): 297, 1974

Use of dopamine in splanchnic artery occlusion shock. Federation Proceedings 36(3): 582, 1977

Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 188(3): 265-271, 1988

Mechanisms of the anti shock effects of human superoxide dismutase in splanchnic artery occlusion sao shock. FASEB Journal 2(5): ABSTRACT 3943, 1988

Arachidonic acid in splanchnic artery occlusion shock. American Journal of Physiology 231(1): 112-119, 1976

Amelioration of splanchnic artery occlusion (SAO) shock by cysteine. Advances in Shock Research 1: 261-270, 1978

Actions of dopamine in splanchnic artery occlusion shock. American Journal of Physiology 234(1): H1-H6, 1978

Therapeutic approaches to splanchnic artery occlusion sao shock in the rat. Pharmacological Research Communications 20(3): 229-230, 1988

Impairment of cardiac function after splanchnic artery occlusion shock. Circulatory Shock 1(2): 123-130, 1974

Release of prostaglandin F2alpha during splanchnic artery occlusion shock. American Journal of Physiology 230(3): 684-690, 1976

Protective actions of cysteine in splanchnic artery occlusion shock. Physiologist 21(4): 41, 1978

Effects of prostacyclin and taprostene in splanchnic artery occlusion shock. Eicosanoids 4(1): 15-20, 1991

Free radical formation during splanchnic artery occlusion shock. Journal of Anesthesia 6(4): 414-425, 1992